The medical products maker now expects sales to grow 9.8% to 10.2% in the full year.

Stryker (SYK) came out with quarterly earnings of $3.19 per share, beating the Zacks Consensus Estimate of $3.14 per share. This compares to earnings of $2.87 per share a year ago. These figures are ...

Medical technology company Stryker (NYSE:SYK) met Wall Streets revenue expectations in Q3 CY2025, with sales up 10.2% year on year to $6.06 billion. Its non-GAAP profit of $3.19 per share was 1.9% ...

Analysts have recently evaluated Stryker and provided 12-month price targets. The average target is $417.57, accompanied by a ...

Stryker on Thursday raised the lower end of its full-year profit forecast after beating estimates for third-quarter earnings, banking on strong demand for its medical and surgical devices.

Stryker Corp (($SYK)) has held its Q3 earnings call. Read on for the main highlights of the call. Stryker Corp’s recent earnings call painted a ...

Stryker (NYSE:SYK) shares dipped slightly today on third-quarter results that topped the consensus Wall Street forecast.

Stryker (SYK) reported current net profit margins of 12.1%, a step down from last year’s 16.3%, with the latest results ...

Portage, Michigan, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2025: Reported net sales increased 10.3% to $6.1 billion Organic net sales ...

The medical device maker posted revenue of $6.06 billion in the period, also beating Street forecasts. Eight analysts surveyed by Zacks expected $6.04 billion. Stryker expects full-year earnings in ...

KALAMAZOO (WWJ) --Stryker Interventional Spine announced the clearance of 510(k)s, United States Food and Drug Administration approval allowing the sale of two additional products in its portfolio.

Stryker is moving to acquire fellow devicemaker Wright Medical in a $4 billion play to gain a stronger foothold in fast-growing orthopedic segments. The Amsterdam and Memphis, Tennessee-based Wright ...